Kamada Ltd (KMDA) Stock Price

KMDAStock

$8.29+18.09%52W

Market Cap$478.29M

P/E20.82x

PEG Ratio0.70

Div yield3.22%

Beta0.92

KMDA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-21.82%

Price vs S&P 500 (4W)13.12%

PEG Ratio0.70

VGM Score56.48

P/E Ratio (Annual)20.82x

Indicated Dividend Yield (Annual)3.22%

P/CF (Annual)16.50x

Book Value / Share (Quarterly)$4.50

P/TBV (Annual)2.35x

Indicated Dividend (Annual)$0.25

Revenue Growth (3Y)0.56%

Cash Flow / Share (Quarterly)$0.28

Price vs S&P 500 (YTD)4.60%

Gross Margin (TTM)37.20%

Net Profit Margin (TTM)11.20%

EPS (TTM)$0.35

10-Day Avg Trading Volume0.20M

EPS Excl Extra (TTM)$0.35

Revenue Growth (5Y)4.70%

EPS (Annual)$0.35

Dividend / Share (Annual)$0.20

ROI (Annual)7.20%

Gross Margin (Annual)38.94%

Net Profit Margin (5Y Avg)9.40%

Cash / Share (Quarterly)$1.27

P/E Basic Excl Extra (TTM)20.65x

Revenue Growth QoQ (YoY)2.82%

EPS Growth (5Y)-2.02%

P/E Normalized (Annual)20.82x

ROA (Last FY)5.33%

Revenue Growth TTM (YoY)31.34%

EBITD / Share (TTM)$0.69

ROE (5Y Avg)7.76%

Operating Margin (TTM)13.96%

Cash Flow / Share (Annual)$0.27

P/B Ratio1.62x

P/B Ratio (Quarterly)1.85x

Net Income / Employee (Annual)$51,400

EV / Revenue (TTM)2.38x

Net Interest Coverage (TTM)206.85x

ROA (TTM)5.41%

EPS Growth QoQ (YoY)0.72%

EV / EBITDA (TTM)10.66x

EPS Incl Extra (Annual)$0.35

Current Ratio (Annual)4.07x

Quick Ratio (Quarterly)1.90x

3-Month Avg Trading Volume0.07M

52-Week Price Return18.09%

EV / Free Cash Flow (Annual)27.63x

P/E Incl Extra (TTM)20.65x

Revenue / Employee (TTM)$462,900

Tangible BV / Share (Quarterly)$3.00

P/S Ratio (Annual)2.95x

Asset Turnover (Annual)0.40x

52-Week High$9.35

Operating Margin (5Y Avg)10.71%

EPS Excl Extra (Annual)$0.35

CapEx CAGR (5Y)-1.91%

Tangible BV CAGR (5Y)-20.17%

26-Week Price Return-9.89%

Quick Ratio (Annual)2.21x

13-Week Price Return5.47%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)3.33x

Enterprise Value$432.23M

Revenue / Share Growth (5Y)1.28%

Asset Turnover (TTM)0.48x

Book Value / Share Growth (5Y)12.05%

Revenue / Employee (Annual)$362,600

Inventory Turnover (Annual)1.14x

Pretax Margin (Annual)5.91%

Cash / Share (Annual)$1.31

3-Month Return Std Dev29.84%

Gross Margin (5Y Avg)35.50%

Net Income / Employee (TTM)$51,800

EBITDA CAGR (5Y)-2.82%

EBITDA Interim CAGR (5Y)11.20%

ROE (Last FY)7.51%

Net Interest Coverage (Annual)8.63x

EPS Basic Excl Extra (Annual)$0.35

P/FCF (TTM)151.21x

Receivables Turnover (TTM)6.17x

EV / Free Cash Flow (TTM)26.42x

Total Debt / Equity (Quarterly)0.04x

EPS Incl Extra (TTM)$0.35

Receivables Turnover (Annual)4.10x

ROI (TTM)7.41%

P/S Ratio (TTM)2.31x

Pretax Margin (5Y Avg)9.50%

Revenue / Share (Annual)$2.66

Tangible BV / Share (Annual)$3.00

Forward P/E13.36x

Free OCF CAGR (5Y)59.69%

Price vs S&P 500 (52W)-0.47%

P/E Ratio (TTM)20.65x

EPS Growth TTM (YoY)150.27%

Year-to-Date Return17.42%

5-Day Price Return-1.66%

EPS Normalized (Annual)$0.35

ROA (5Y Avg)5.37%

Net Profit Margin (Annual)5.81%

Month-to-Date Return16.11%

Cash Flow / Share (TTM)$0.39

EBITD / Share (Annual)$0.48

Operating Margin (Annual)7.06%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)16.36x

ROI (5Y Avg)6.53%

P/E Excl Extra (TTM)20.65x

LT Debt / Equity (Quarterly)1.98x

EPS Basic Excl Extra (TTM)$0.35

P/TBV (Quarterly)2.35x

Payout Ratio (Annual)57.10%

P/B Ratio (Annual)1.51x

Dividend / Share (TTM)$0.22

Inventory Turnover (TTM)1.31x

Pretax Margin (TTM)12.23%

Book Value / Share (Annual)$4.66

Price vs S&P 500 (13W)3.52%

Net Margin Growth (5Y)-2.71%

Dividend Yield (TTM)2.96%

Beta0.92x

P/FCF (Annual)26.88x

Revenue / Share (TTM)$3.08

ROE (TTM)7.73%

52-Week Low$6.50

vGradeC

gGradeC

mGradeC

vgmGradeC

KMDA Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 12, 2026	$0.11	$0.16	+42.22%(+$0.05)
Q1 2026	May 13, 2026	$0.12	$0.07	-39.13%(-$0.05)
Q4 2025	Mar 11, 2026	$0.08	$0.06	-22.58%(-$0.02)
Q3 2025	Nov 10, 2025	$0.09	$0.09	-2.70%(-$0.00)
Q2 2025	Aug 13, 2025	$0.09	$0.13	+44.44%(+$0.04)

KMDA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.22

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
KMDAKamada Ltd	C	C	C	$8.29
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Kamada Ltd

Kamada Ltd is a biopharmaceutical company that develops and markets plasma-derived protein therapeutics for specialty diseases across multiple therapeutic areas including hemophilia, lung disease, immunoglobulin deficiencies, vaccines, critical care, and diagnostics. The company's proprietary portfolio includes key products such as Glassia, Bramitob, Foster, and Ixiaro. Revenue is primarily generated from proprietary products, with a secondary distribution segment.